Application of a new method for GWAS in a related case/control sample with known pedigree structure: Identification of new loci for nephrolithiasis

PLoS Genetics

Volumn 7, Issue 1, 2011, Pages

  Tore, Silvia ^a   Casula, Stefania ^a   Casu, Giuseppina ^a   Concas, Maria Pina ^a   Pistidda, Paola ^a   Persico, Ivana ^a   Sassu, Alessandro ^b   Maestrale, Giovanni Battista ^a   Mele, Caterina ^c   Caruso, Maria Rosa ^d   Bonerba, Bibiana ^e   Usai, Paolo ^f   Deiana, Ivo ^g   Thornton, Timothy ^h   Pirastu, Mario ^a,b   Forabosco, Paola ^a  

^a CNR   (Italy)

^b Shardna Life Sciences   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f SS Trinit Hospital   (Italy)

^g Osp Nostra Signora della Mercede   (Italy)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; GENE PRODUCT; PROTEIN LRRC16A; UNCLASSIFIED DRUG; URIC ACID; CARMIL1 PROTEIN, HUMAN; CARRIER PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE ISOLATION; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC DATABASE; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; INBREEDING DEPRESSION; ITALY; NEPHROLITHIASIS; PEDIGREE ANALYSIS; POPULATION GENETIC STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; URIC ACID BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GOUT; METABOLISM; METHODOLOGY; PEDIGREE; STATISTICAL ANALYSIS;

CARRIER PROTEINS; CASE-CONTROL STUDIES; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GOUT; HUMANS; ITALY; NEPHROLITHIASIS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; URIC ACID;

EID: 79851505592     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001281     Document Type: Article

References (46)

1. Rivers K, Shetty S, Menon M (2000) When and how to evaluate a patient with nephrolithiasis. Urol Clin North Am 27: 203-213.
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823.
3. Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H (1994) Demographic and geographic variability of kidney stones in the United States. Kidney Int 46: 893-899.
4. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115: 26-32.
5. Bid HK, Chaudhary H, Mittal RD (2005) Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr Nephrol 20: 773-776.
6. Onaran M, Yilmaz A, Sen I, Ergun MA, Camtosun A, et al. (2009) A HindIII polymorphism of fibronectin gene is associated with nephrolithiasis. Urology 74: 1004-1007.
7. Sayer JA (2008) The genetics of nephrolithiasis. Nephron Exp Nephrol 110: e37-43.
8. Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A 105: 9841-9846.
9. Alvarez-Nemegyei J, Medina-Escobedo M, Villanueva-Jorge S, Vazquez-Mellado J (2005) Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed? J Rheumatol 32: 2189-2191.
10. Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17: 304-309.
11. Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH (2001) Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60: 757-761.
12. Angius A, Hyland FC, Persico I, Pirastu N, Woodage T, et al. (2008) Patterns of linkage disequilibrium between SNPs in a Sardinian population isolate and the selection of markers for association studies. Hum Hered 65: 9-22.
13. Fraumene C, Belle EM, Castri L, Sanna S, Mancosu G, et al. (2006) High resolution analysis and phylogenetic network construction using complete mtDNA sequences in sardinian genetic isolates. Mol Biol Evol 23: 2101-2111.
14. Ombra MN, Forabosco P, Casula S, Angius A, Maestrale G, et al. (2001) Identification of a new candidate locus for uric acid nephrolithiasis. Am J Hum Genet 68: 1119-1129.
15. Gianfrancesco F, Esposito T, Ombra MN, Forabosco P, Maninchedda G, et al. (2003) Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate. Am J Hum Genet 72: 1479-1491.
16. Bourgain C, Hoffjan S, Nicolae R, Newman D, Steiner L, et al. (2003) Novel case-control test in a founder population identifies P-selectin as an atopy-susceptibility locus. Am J Hum Genet 73: 612-626.
17. Slager SL, Schaid DJ (2001) Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. Am J Hum Genet 68: 1457-1462.
18. Thornton T, McPeek MS (2007) Case-control association testing with related individuals: a more powerful quasi-likelihood score test. Am J Hum Genet 81: 321-337.
19. Lasky-Su J, Won S, Mick E, Anney RJ, Franke B, et al. (2010) On genome-wide association studies for family-based designs: an integrative analysis approach combining ascertained family samples with unselected controls. Am J Hum Genet 86: 573-580.
20. Thornton T, McPeek MS (2010) ROADTRIPS: case-control association testing with partially or completely unknown population and pedigree structure. Am J Hum Genet 86: 172-184.
21. Price AL, Zaitlen NA, Reich D, Patterson N (2010) New approaches to population stratification in genome-wide association studies. Nat Rev Genet 11: 459-463.
22. Pollack HM, Arger PH, Goldberg BB, Mulholland SG (1978) Ultrasonic detection of nonopaque renal calculi. Radiology 127: 233-237.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
24. Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55: 997-1004.
25. McPeek MS, Wu X, Ober C (2004) Best linear unbiased allele-frequency estimation in complex pedigrees. Biometrics 60: 359-367.
26. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
27. Falchi M, Forabosco P, Mocci E, Borlino CC, Picciau A, et al. (2004) A genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia. Am J Hum Genet 75: 1015-1031.
28. Browning SR, Briley JD, Briley LP, Chandra G, Charnecki JH, et al. (2005) Case-control single-marker and haplotypic association analysis of pedigree data. Genet Epidemiol 28: 110-122.
29. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, et al. (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5: e1000504 doi:10.1371/journal.pgen.1000504.
30. Yang C, Pring M, Wear MA, Huang M, Cooper JA, et al. (2005) Mammalian CARMIL inhibits actin filament capping by capping protein. Dev Cell 9: 209-221.
31. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P (2007) Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17: 428-437.
32. Coward RJ, Welsh GI, Yang J, Tasman C, Lennon R, et al. (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54: 3095-3102.
33. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65: 386-392.
34. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
35. Deitel M (2003) Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 13: 329-330.
36. Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. Jama 293: 455-462.
37. Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68: 1230-1235.
38. Primakoff P, Myles DG (2000) The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 16: 83-87.
39. Ru QC, Katenhusen RA, Zhu LA, Silberman J, Yang S, et al. (2006) Proteomic profiling of human urine using multi-dimensional protein identification technology. J Chromatogr A 1111: 166-174.
40. White JM (2003) ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15: 598-606.
41. Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, et al. (2003) ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem 278: 9576-9584.
42. Ombra MN, Casula S, Biino G, Maestrale G, Cardia F, et al. (2003) Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate. Urology 62: 416-420.
43. Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Matsuo S, et al. (2001) Syndecan-4 deficiency increases susceptibility to kappa-carrageenan-induced renal damage. Lab Invest 81: 509-516.
44. Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS (2007) A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet 8 (Suppl 1): S10.
45. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939.
46. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.